The CD8+ T cell response to Epstein-Barr virus (EBV) is well characterized. Much less is known about the evolution of the CD4+ T cell response. Here we show that EBV stimulates a primary burst of effector CD4+ T cells and this is followed by a period of down-regulation. A small population of EBV-specific effector CD4+ T cells survives during the lifelong persistent phase of infection. The EBV-specific effector CD4+ T cells accumulate within a CD27+ CD28+ differentiation compartment during primary infection and remain enriched within this compartment throughout the persistent phase of infection. Analysis of CD4+ T cell responses to individual epitopes from EBV latent and lytic cycle proteins confirms the observation that the majority of the effector cells express both CD27 and CD28, although CD4+ T cells specific for lytic cycle antigens have a greater tendency to express CD45RA than those specific for the latent antigens. In clear contrast, effector CD4+ T cells specific for cytomegalovirus (CMV) accumulate within the CD27− CD28+ and CD27− CD28− compartments. There are striking parallels in terms of the differentiation of CD8+ T cells specific for EBV and CMV. The results challenge current ideas on the definition of memory subsets.
Skip Nav Destination
Article navigation
15 September 2003
Article|
September 15 2003
Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection
Elisabeth Amyes,
Elisabeth Amyes
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Search for other works by this author on:
Chris Hatton,
Chris Hatton
2Department of Haematology, The John Radcliffe, OX3 9DS Oxford, United Kingdom
Search for other works by this author on:
Damien Montamat-Sicotte,
Damien Montamat-Sicotte
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Search for other works by this author on:
Nancy Gudgeon,
Nancy Gudgeon
3Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom
Search for other works by this author on:
Alan B. Rickinson,
Alan B. Rickinson
3Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom
Search for other works by this author on:
Andrew J. McMichael,
Andrew J. McMichael
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Search for other works by this author on:
Margaret F.C. Callan
Margaret F.C. Callan
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Search for other works by this author on:
Elisabeth Amyes
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Chris Hatton
2Department of Haematology, The John Radcliffe, OX3 9DS Oxford, United Kingdom
Damien Montamat-Sicotte
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Nancy Gudgeon
3Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom
Alan B. Rickinson
3Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, B15 2TT Birmingham, United Kingdom
Andrew J. McMichael
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Margaret F.C. Callan
1Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine
Address correspondence to Margaret Callan, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, The John Radcliffe, OX3 9DS Oxford, United Kingdom. Phone: 44-1865-222448; Fax: 44-1865-222502; email: [email protected]
Abbreviations used in this paper: EBNA, EBV nuclear antigen; IM, infectious mononucleosis; MOI, multiplicity of infection.
Received:
November 26 2002
Revision Received:
July 07 2003
Accepted:
July 24 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (6): 903–911.
Article history
Received:
November 26 2002
Revision Received:
July 07 2003
Accepted:
July 24 2003
Citation
Elisabeth Amyes, Chris Hatton, Damien Montamat-Sicotte, Nancy Gudgeon, Alan B. Rickinson, Andrew J. McMichael, Margaret F.C. Callan; Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection . J Exp Med 15 September 2003; 198 (6): 903–911. doi: https://doi.org/10.1084/jem.20022058
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement